NES
MDCO

New England Securities’s Medicines Co MDCO Stock Holding History

New England Securities’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-350
Closed -$10K – 1791
2014
Q2 		$10K Sell
350
-100
-22% -$2.67K ﹤0.01% 1131
2014
Q1 		$13K Hold
450
– – 0.01% 1000
2013
Q4 		$17K Hold
450
– – 0.01% 891
2013
Q3 		$15K Buy
450
+50
+13% +$1.59K 0.01% 861
2013
Q2 		$12K Buy
+400
New +$13.4K 0.01% 831

Other funds holding MDCO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

New England Securities's MDCO Position: Q3 2014 in Review

New England Securities sold out of Medicines Co (MDCO) in Q3 2014, closing a stake of 350 shares — an estimated $10K sold.

New England Securities first reported a position in MDCO in Q2 2013 and held it in 5 quarters. The position peaked at $17K in Q4 2013. 152 funds tracked by Wall St. Rank hold MDCO as of Q3 2014.

  • New England Securities reported no remaining Medicines Co position as of Q3 2014 after selling out during the quarter.
  • New England Securities sold 350 Medicines Co shares in Q3 2014, an estimated $10K.
  • New England Securities first reported a position in Medicines Co in Q2 2013 and held it in 5 quarters.
  • New England Securities's Medicines Co position peaked at $17K in Q4 2013.
  • 152 funds tracked by Wall St. Rank held Medicines Co as of Q3 2014.

Based on New England Securities's 13F filing for Q3 2014, filed 5 Nov 2014.